EA1211: interim FDG-PET/CT for predicting response of HER2-positive breast cancer to neoadjuvant therapy (DIRECT trial). Academic Article

Overview

abstract

NCT05710328.

authors

Hennessy, Maeve A

Gatsonis, Constantine

Jacene, Heather

Connolly, Roisin M

Burnette, Brian L

Stringer-Reasor, Erica M

Romanoff, Justin

Taurone, Alexander

O'Sullivan, Ciara C

Le-Petross, Huong T

Stearns, Vered
Fowler, Amy M
Tang, Shou-Ching
Sepulveda, Karla A
DeMichele, Angela M
Mankoff, David A
Wolff, Antonio C

publication date

October 5, 2025

published in

Future oncology (London, England) Journal

Research

keywords

Breast Neoplasms
Positron Emission Tomography Computed Tomography
Receptor, ErbB-2

Identity

Digital Object Identifier (DOI)

10.1080/14796694.2025.2567840

PubMed ID

41047708